长链非编码 RNA SNHG14 通过隔离 miR-152-3p 促进弥漫性大 B 细胞淋巴瘤的发生和免疫逃逸。
lncRNA SNHG14 promotes oncogenesis and immune evasion in diffuse large-B-cell lymphoma by sequestering miR-152-3p.
机构信息
Department of Hematology, Hainan Cancer Hospital, Haikou, China.
Department of Hematology, Huai'an Hospital Affiliated to Xuzhou Medical College and Huai'an Second People's Hospital, China.
出版信息
Leuk Lymphoma. 2021 Jul;62(7):1574-1584. doi: 10.1080/10428194.2021.1876866. Epub 2021 Mar 8.
This study aimed to explore the role of small nucleolar RNA host gene 14 (SNHG14) in the pathogenesis of diffuse large-B-cell lymphoma (DLBCL). DLBCL cell lines (OCI-Ly7 and OCI-Ly3) and specimens from patients were collected to evaluate the roles of SNHG14 in DLBCL pathogenesis. The results showed that SNHG14 expression increased and miR-152-3p expression decreased in DLBCL tissues and cell lines, indicating a negative correlation between miR-152-3p and SNHG14 expression. Moreover, SNHG14 was found to promote DLBCL growth, migration, and EMT-like processes , and directly inhibits miR-152-3p gene expression sequestration of the miR-152-3p transcripts in DLBCL. Additionally, SNHG14/miR-152-3p inhibits apoptosis and promotes cell proliferation on cytotoxic T lymphocytes (CTLs) in DLBCL the PD-1/PD-L1 checkpoint. Furthermore, both the immune escape and progression of DLBCL are advanced by SNHG14 expression its interactions with miR-152-3p. Collective, this suggests that SNHG14 is a potential diagnostic, prognostic, and therapeutic target for DLBCL.
本研究旨在探讨小核仁 RNA 宿主基因 14(SNHG14)在弥漫性大 B 细胞淋巴瘤(DLBCL)发病机制中的作用。收集了 DLBCL 细胞系(OCI-Ly7 和 OCI-Ly3)和患者标本,以评估 SNHG14 在 DLBCL 发病机制中的作用。结果表明,SNHG14 在 DLBCL 组织和细胞系中的表达增加,miR-152-3p 的表达减少,表明 miR-152-3p 与 SNHG14 表达呈负相关。此外,SNHG14 被发现可促进 DLBCL 的生长、迁移和 EMT 样过程,并直接抑制 miR-152-3p 基因的表达,从而抑制 miR-152-3p 转录本在 DLBCL 中的蓄积。此外,SNHG14/miR-152-3p 在 DLBCL 中抑制细胞毒性 T 淋巴细胞(CTLs)的凋亡并促进细胞增殖,抑制 PD-1/PD-L1 检查点。此外,SNHG14 的表达及其与 miR-152-3p 的相互作用可促进 DLBCL 的免疫逃逸和进展。综上表明,SNHG14 可能是 DLBCL 的一个潜在的诊断、预后和治疗靶点。